Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 132Terminated 45Recruiting 26Active not recruiting 16Withdrawn 10Unknown 8Not yet recruiting 5No longer available 1

Sponsor Class

OTHER 2NIH 2INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 3Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia 2Lymphoma 1Leukemia, Myeloid 1Hematologic Neoplasms 1

Interventions

venetoclax 37Azacitidine 23fludarabine 19Cytarabine 19Cyclophosphamide 15Specimen Handling 14blinatumomab 13Biopsy 12Busulfan 8Dexamethasone 7Melphalan 6Daunorubicin 6Whole-Body Irradiation 5Vincristine 5Thiotepa 5Methotrexate 5gilteritinib 4daratumumab 4Tacrolimus 4Stem Cell Transplantation 4Magnetic Resonance Spectroscopy 4Imatinib Mesylate 4Idarubicin 4Decitabine 4Blood Specimen Collection 4zanubrutinib 3selinexor 3ruxolitinib 3revumenib 3olutasidenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Whole-Body Irradiation × Other hematologic neoplasm × Clear all
NCT07524530 2026-05-27

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT06954987 2026-05-13

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
244 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

Baptist Health South Florida

Phase 2 Not yet recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07157514 2025-09-10

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Actinium Pharmaceuticals

Phase 2/3 Not yet recruiting
306 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT06175702 2023-12-19

LALPh2022

PETHEMA Foundation

Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡